Real-World Outcomes of Patients With CLL Treated With Ibrutinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, Canada
Leukemia and Lymphoma 2023 Apr 22;[EPub Ahead of Print], RS Khelifi, SJ Huang, KJ Savage, D Villa, DW Scott, K Ramadan, JM Connors, LH Sehn, CL Toze, AS GerrieFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.